$RMD
RESMED INC

2019 Q4 Form 10-Q Financial Statement

#000094381920000003 Filed on January 31, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4
Revenue $736.2M $651.1M
YoY Change 13.06% 8.29%
Cost Of Revenue $309.0M $276.6M
YoY Change 11.74% 9.98%
Gross Profit $427.1M $374.5M
YoY Change 14.04% 7.07%
Gross Profit Margin 58.02% 57.52%
Selling, General & Admin $171.4M $161.6M
YoY Change 6.09% 6.43%
% of Gross Profit 40.13% 43.14%
Research & Development $49.94M $43.11M
YoY Change 15.85% 6.07%
% of Gross Profit 11.69% 11.51%
Depreciation & Amortization $39.12M $36.10M
YoY Change 8.37% 23.21%
% of Gross Profit 9.16% 9.64%
Operating Expenses $229.3M $217.5M
YoY Change 5.46% 6.71%
Operating Profit $197.8M $157.1M
YoY Change 25.93% 7.58%
Interest Expense $10.22M $7.487M
YoY Change 36.5% 1.59%
% of Operating Profit 5.17% 4.77%
Other Income/Expense, Net -$19.06M -$10.81M
YoY Change 76.37% 154.18%
Pretax Income $178.8M $146.3M
YoY Change 22.2% 3.18%
Income Tax $18.20M $21.63M
% Of Pretax Income 10.18% 14.79%
Net Earnings $160.6M $124.6M
YoY Change 28.82% 1208.27%
Net Earnings / Revenue 21.81% 19.14%
Basic Earnings Per Share $1.11 $0.87
Diluted Earnings Per Share $1.10 $0.86
COMMON SHARES
Basic Shares Outstanding 144.2M 142.9M
Diluted Shares Outstanding 145.6M 144.3M

Balance Sheet

Concept 2019 Q4 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $204.1M $149.5M
YoY Change 36.52% -82.59%
Cash & Equivalents $204.1M $149.5M
Short-Term Investments
Other Short-Term Assets $182.8M $140.4M
YoY Change 30.2% 20.52%
Inventory $377.8M $296.5M
Prepaid Expenses
Receivables $528.0M $477.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.300B $1.064B
YoY Change 22.28% -39.38%
LONG-TERM ASSETS
Property, Plant & Equipment $408.4M $381.5M
YoY Change 7.04% -4.98%
Goodwill $1.871B $1.759B
YoY Change 6.34%
Intangibles
YoY Change
Long-Term Investments $54.70M $62.86M
YoY Change -12.98% 57.96%
Other Assets $163.9M $138.1M
YoY Change 18.72% 48.81%
Total Long-Term Assets $3.053B $2.796B
YoY Change 9.2% 54.52%
TOTAL ASSETS
Total Short-Term Assets $1.300B $1.064B
Total Long-Term Assets $3.053B $2.796B
Total Assets $4.354B $3.860B
YoY Change 12.8% 8.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.3M $110.3M
YoY Change 3.61% 40.73%
Accrued Expenses $217.8M $191.6M
YoY Change 13.72% 2.17%
Deferred Revenue $92.95M $72.69M
YoY Change 27.88%
Short-Term Debt $11.98M $11.98M
YoY Change 0.05%
Long-Term Debt Due $12.00M $12.00M
YoY Change 0.0% -98.82%
Total Short-Term Liabilities $500.0M $436.4M
YoY Change 14.57% -67.82%
LONG-TERM LIABILITIES
Long-Term Debt $1.288B $1.186B
YoY Change 8.6%
Other Long-Term Liabilities $2.062M $202.8M
YoY Change -98.98% 15.95%
Total Long-Term Liabilities $1.596B $1.467B
YoY Change 8.75% 738.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $500.0M $436.4M
Total Long-Term Liabilities $1.596B $1.467B
Total Liabilities $2.096B $1.904B
YoY Change 10.09% 23.26%
SHAREHOLDERS EQUITY
Retained Earnings $2.605B $2.368B
YoY Change 9.99%
Common Stock $1.522B $1.461B
YoY Change 4.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B $1.623B
YoY Change 0.0%
Treasury Stock Shares $41.84M $41.84M
Shareholders Equity $2.258B $1.956B
YoY Change
Total Liabilities & Shareholders Equity $4.354B $3.860B
YoY Change 12.8% 8.3%

Cashflow Statement

Concept 2019 Q4 2018 Q4
OPERATING ACTIVITIES
Net Income $160.6M $124.6M
YoY Change 28.82% 1208.27%
Depreciation, Depletion And Amortization $39.12M $36.10M
YoY Change 8.37% 23.21%
Cash From Operating Activities $69.90M $129.5M
YoY Change -46.02% -2.26%
INVESTING ACTIVITIES
Capital Expenditures -$27.90M -$20.50M
YoY Change 36.1% 12.02%
Acquisitions
YoY Change
Other Investing Activities -$15.70M -$637.7M
YoY Change -97.54% 6341.41%
Cash From Investing Activities -$43.60M -$658.2M
YoY Change -93.38% 2225.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 800.0K 450.2M
YoY Change -99.82% -912.64%
NET CHANGE
Cash From Operating Activities 69.90M 129.5M
Cash From Investing Activities -43.60M -658.2M
Cash From Financing Activities 800.0K 450.2M
Net Change In Cash 27.10M -78.50M
YoY Change -134.52% -260.86%
FREE CASH FLOW
Cash From Operating Activities $69.90M $129.5M
Capital Expenditures -$27.90M -$20.50M
Free Cash Flow $97.80M $150.0M
YoY Change -34.8% -0.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Address Country
EntityAddressCountry
US
dei Entity Central Index Key
EntityCentralIndexKey
0000943819
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-15317
dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2018Q4 us-gaap Investments
Investments
62859000
dei Local Phone Number
LocalPhoneNumber
836-5000
CY2019Q4 us-gaap Goodwill
Goodwill
1870647000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
190567000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
dei Trading Symbol
TradingSymbol
RMD
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
120113000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1300485000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
1145366000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
408364000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387460000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
144616947
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204095000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26854000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25171000
dei City Area Code
CityAreaCode
858
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
528039000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
528484000
CY2019Q4 us-gaap Inventory Net
InventoryNet
377784000
CY2019Q2 us-gaap Inventory Net
InventoryNet
349641000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
96745000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q2 us-gaap Goodwill
Goodwill
1856449000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
480861000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
521950000
CY2019Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
32889000
CY2019Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
45478000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163948000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150979000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3053454000
CY2019Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2962316000
CY2019Q4 us-gaap Assets
Assets
4353939000
CY2019Q2 us-gaap Assets
Assets
4107682000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
114322000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
115725000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
217847000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
266359000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20038000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92950000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
88667000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
42904000
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
73248000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11984000
CY2019Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11992000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
500045000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
555991000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
86140000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
81143000
CY2019Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
27709000
CY2019Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
11380000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79458000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2062000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2058000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1287509000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1258861000
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
112910000
CY2019Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
126056000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1595788000
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1479498000
CY2019Q4 us-gaap Liabilities
Liabilities
2095833000
CY2019Q2 us-gaap Liabilities
Liabilities
2035489000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2018Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161579000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
338862000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186434945
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144598711
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
185491064
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143654830
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
578000
CY2019Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
575000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1521992000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1511473000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2604910000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2436410000
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-246118000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253009000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2258106000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4353939000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4107682000
CY2019Q4 us-gaap Revenues
Revenues
736157000
CY2018Q4 us-gaap Revenues
Revenues
651100000
us-gaap Revenues
Revenues
1417213000
us-gaap Revenues
Revenues
1239380000
CY2019Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
296975000
CY2018Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
267369000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
572976000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
512556000
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12052000
CY2018Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9199000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25488000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16154000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
309027000
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
276568000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
598464000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
528710000
CY2019Q4 us-gaap Gross Profit
GrossProfit
427130000
CY2018Q4 us-gaap Gross Profit
GrossProfit
374532000
us-gaap Gross Profit
GrossProfit
818749000
us-gaap Gross Profit
GrossProfit
710670000
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
171422000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
308881000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49943000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43111000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97976000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81902000
CY2019Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
8556000
CY2018Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
6641000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
13599000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
12553000
CY2019Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Net Income Loss
NetIncomeLoss
230377000
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2018Q4 rmd Acquisition Related Expenses
AcquisitionRelatedExpenses
6123000
rmd Acquisition Related Expenses
AcquisitionRelatedExpenses
6123000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
229321000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
217454000
us-gaap Operating Expenses
OperatingExpenses
449837000
us-gaap Operating Expenses
OperatingExpenses
409459000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
197809000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
157078000
us-gaap Operating Income Loss
OperatingIncomeLoss
368912000
us-gaap Operating Income Loss
OperatingIncomeLoss
301211000
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
202000
CY2018Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
678000
us-gaap Investment Income Interest
InvestmentIncomeInterest
650000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1600000
CY2019Q4 us-gaap Interest Expense
InterestExpense
10220000
CY2018Q4 us-gaap Interest Expense
InterestExpense
7487000
us-gaap Interest Expense
InterestExpense
21212000
us-gaap Interest Expense
InterestExpense
11195000
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6924000
CY2018Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3375000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13786000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3375000
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2115000
CY2018Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-621000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5225000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3086000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19057000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10805000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39573000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16056000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
178752000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
146273000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
329339000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
285155000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18198000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21634000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48637000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54778000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
us-gaap Net Income Loss
NetIncomeLoss
280702000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.93
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
513000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-141000
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2018Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.74
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144212000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142923000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143966000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142796000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145575000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144349000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145479000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144418000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
us-gaap Net Income Loss
NetIncomeLoss
280702000
us-gaap Net Income Loss
NetIncomeLoss
230377000
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44467000
CY2018Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13117000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6891000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25989000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
205021000
CY2018Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111522000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
287593000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
204388000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5609000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-327000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13256000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37576000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2019Q3 us-gaap Dividends
Dividends
56052000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
2117251000
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6498000
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-40761000
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12190000
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14057000
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44467000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
CY2019Q4 us-gaap Dividends
Dividends
56150000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2258106000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2058980000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12872000
CY2018Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22845000
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12476000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27967000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
105738000
CY2018Q3 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-188799000
CY2018Q3 us-gaap Dividends
Dividends
52794000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1900256000
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1263000
CY2018Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-27341000
CY2018Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10576000
CY2018Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12541000
CY2018Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13117000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
CY2018Q4 us-gaap Dividends
Dividends
52773000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1956044000
us-gaap Net Income Loss
NetIncomeLoss
280702000
us-gaap Net Income Loss
NetIncomeLoss
230377000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77077000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66453000
rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
12323000
us-gaap Share Based Compensation
ShareBasedCompensation
27309000
us-gaap Share Based Compensation
ShareBasedCompensation
25011000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13786000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3375000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
5419000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2959000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-272000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32366000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28294000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30570000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66818000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26922000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-88927000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-125190000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
232295000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177587000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47771000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31425000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4871000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4643000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3423000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
739249000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
21841000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
3127000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-1064000
CY2019Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3139000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76842000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-806411000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24297000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12784000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-41091000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-27340000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22844000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
302000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
430000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
730000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1091230000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
700012000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
352798000
us-gaap Payments Of Dividends
PaymentsOfDividends
112202000
us-gaap Payments Of Dividends
PaymentsOfDividends
105567000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-99310000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
595035000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
824000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5444000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56967000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39233000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188701000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204095000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149468000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
141948000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
192497000
us-gaap Interest Paid Net
InterestPaidNet
21212000
us-gaap Interest Paid Net
InterestPaidNet
11195000
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
3000000
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
343470000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
298554000
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
695353000
rmd Noncash Or Part Noncash Acquisition Deferred Payments
NoncashOrPartNoncashAcquisitionDeferredPayments
423000
rmd Noncash Or Part Noncash Acquisition Deferred Payments
NoncashOrPartNoncashAcquisitionDeferredPayments
-852000
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
168000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3423000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
739249000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
6400000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1287509000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1258861000
CY2019Q2 rmd Lessee Operating Lease Estimated Discount Rate
LesseeOperatingLeaseEstimatedDiscountRate
0.035
CY2018Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9199000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16154000
CY2018Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9199000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16154000
CY2018Q4 us-gaap Gross Profit
GrossProfit
374532000
us-gaap Gross Profit
GrossProfit
710670000
CY2019Q4 us-gaap Revenues
Revenues
736157000
CY2018Q4 us-gaap Revenues
Revenues
651100000
us-gaap Revenues
Revenues
1417213000
us-gaap Revenues
Revenues
1239380000
CY2019Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
CY2018Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6123000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6123000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
98047000
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
80861000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2063000
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2256000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
277674000
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
266524000
CY2019Q4 us-gaap Inventory Net
InventoryNet
377784000
CY2019Q2 us-gaap Inventory Net
InventoryNet
349641000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
947877000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
898975000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
539513000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
511515000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
408364000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387460000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
480861000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
521950000
CY2019Q2 us-gaap Goodwill
Goodwill
1856449000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16808000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2610000
CY2019Q4 us-gaap Goodwill
Goodwill
1870647000
CY2019Q4 us-gaap Investments
Investments
54739000
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1299493000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19625000
CY2018Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19227000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
6776000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7832000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6191000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7253000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-76000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
431000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
20286000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19375000
CY2019Q4 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2019Q2 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12012000
CY2019Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
16000
CY2019Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
20000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11984000
CY2019Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11992000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1292000000
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1262000000
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4491000
CY2019Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1270853000
rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
CY2019Q4 us-gaap Senior Notes
SeniorNotes
500000000.0
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
12403000
us-gaap Operating Lease Cost
OperatingLeaseCost
12400000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
96745000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20038000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79458000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
99496000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0286
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
114513000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11747000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
20482000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
16022000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13025000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9952000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8202000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
35083000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15017000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
99496000
CY2019Q4 rmd Lessee Operating Lease Lease Not Yet Commenced Commitments
LesseeOperatingLeaseLeaseNotYetCommencedCommitments
35400000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
23400000
CY2017 us-gaap Operating Lease Cost
OperatingLeaseCost
21100000
CY2016 us-gaap Operating Lease Cost
OperatingLeaseCost
20100000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
98013000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
23500000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9478000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
17161000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1513000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1622000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
7916000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
27555000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
41800000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1600000000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22800000
CY2019Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
12900000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1260114
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
72.91
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
162180
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
146.34
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
226773
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
53.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4342
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
110.19
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1191179
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
86.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
146.34
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
753219
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
69.96
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
137000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
129000
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73509000
CY2018Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
161036000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
88624
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85521
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
us-gaap Net Income Loss
NetIncomeLoss
280702000
us-gaap Net Income Loss
NetIncomeLoss
230377000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144212000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142923000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143966000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142796000
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1363000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144349000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145575000
CY2018Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1426000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145479000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144418000
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.60
rmd Receivables Sold Amount
ReceivablesSoldAmount
59338000
rmd Receivables Sold Amount
ReceivablesSoldAmount
60322000
CY2019Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
27446000
CY2019Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
29450000
CY2019Q4 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
3841000
CY2019Q2 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
1752000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6100000

Files In Submission

Name View Source Status
0000943819-20-000003-index-headers.html Edgar Link pending
0000943819-20-000003-index.html Edgar Link pending
0000943819-20-000003.txt Edgar Link pending
0000943819-20-000003-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20191231.xsd Edgar Link pending
rmd-20191231x10q.htm Edgar Link pending
rmd-20191231x10q_htm.xml Edgar Link completed
rmd-20191231xex31_1.htm Edgar Link pending
rmd-20191231xex31_2.htm Edgar Link pending
rmd-20191231xex32.htm Edgar Link pending
rmd-20191231_cal.xml Edgar Link unprocessable
rmd-20191231_def.xml Edgar Link unprocessable
rmd-20191231_lab.xml Edgar Link unprocessable
rmd-20191231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending